LDR Announces Exercise of Over-Allotment Option

AUSTIN, Texas, June 9, 2014 (GLOBE NEWSWIRE) -- LDR Holding Corporation (Nasdaq:LDRH) ("LDR" or the "Company"), a global medical device company focused on designing and commercializing novel and proprietary spinal surgical technologies, today announced that it received notice that the underwriters for its previously announced follow-on offering have exercised their over-allotment option in full to purchase 195,000 additional shares of common stock from the Company and 400,813 additional shares of common stock from the selling stockholders. The purchase price for the shares sold by both the Company and the selling stockholders is $24.50 per share. The Company will not receive any of the proceeds from the sale of shares sold by the selling stockholders.

Help employers find you! Check out all the jobs and post your resume.